Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

HealthLynked (HLYK) EBIAT (2016 - 2025)

HealthLynked (HLYK) has disclosed EBIAT for 10 consecutive years, with -$851800.0 as the latest value for Q3 2025.

  • On a quarterly basis, EBIAT rose 56.83% to -$851800.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.8 million, a 38.03% increase, with the full-year FY2024 number at -$6.1 million, down 69.66% from a year prior.
  • EBIAT was -$851800.0 for Q3 2025 at HealthLynked, down from -$701038.0 in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $1.5 million in Q1 2023 to a low of -$7.8 million in Q1 2021.
  • A 5-year average of -$1.5 million and a median of -$1.2 million in 2024 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: tumbled 1248.37% in 2021, then soared 224.3% in 2023.
  • HealthLynked's EBIAT stood at -$1.7 million in 2021, then plummeted by 105.54% to -$3.5 million in 2022, then soared by 63.53% to -$1.3 million in 2023, then increased by 4.32% to -$1.2 million in 2024, then soared by 30.76% to -$851800.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's EBIAT are -$851800.0 (Q3 2025), -$701038.0 (Q2 2025), and -$1.1 million (Q1 2025).